Clinical trial
18F-αvβ6-binding-peptide PET/CT in Patients Post SARS CoV2 Infection
NCT04376593 is registered in ClinicalTrials.gov with University of California, Davis as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- 18F-αvβ6-binding-peptide PET/CT in Patients Post SARS CoV2 Infection
- Lead sponsor
- University of California, Davis
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- May 1, 2020
- Completion date
- February 23, 2026
- Enrollment
- 5 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid-19, sars-cov-2 infection